• Why Attend?
  • Agenda
  • Advisory Board
  • Speakers
  • Plan Your Visit
  • Event Gallery
  • Sponsors
  • Why partner?
  • Resources
  • Contact Us

Why Attend?

This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining our OCT, CTS and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about latest developments.

 

 

WHAT TO EXPECT FOR 2026?

400+

Attendees

30+

Exhibitors

30+

Speakers
400+

Attendees

30+

Exhibitors
30+

Speakers

Testimonials

See What It's All About

Featured Sponsors

Back

Company Information

ARENSIA Exploratory Medicine, a German-based company, is a leader in “first-in-patient” Phase IB and II/Proof-of-Concept clinical trials across a wide range of disease areas. With 14 proprietary research clinics and cutting-edge Phase I infrastructure, ARENSIA accelerates the early detection of efficacy signals for new therapies at an unparalleled speed. Its streamlined, highly efficient approach reduces patient recruitment time and costs by over 50% compared to conventional trial sites, which are often overcrowded and understaffed. This exceptional performance has resulted in a 93% repeat business rate and robust growth through collaborations with top pharmaceutical companies, biotechs, and global CROs. Headquartered in Düsseldorf, ARENSIA operates with a team of 600 professionals across 8 countries.

Company Website

To learn more, please visit our website - http://www.arensia-em.com/

Next Sponsor
Back

Company Information

Biorce builds AI infrastructure for clinical trials. Our platform, Aika, accelerates how pharmaceutical companies, biotechs, and CROs design and execute clinical research—reducing protocol development time by at least 50% while eliminating costly amendments that delay patient access to life-saving treatments. Built on a foundation of 1 million clinical trials, Aika delivers evidence-based recommendations with complete regulatory transparency. Every decision auditable and defensible before agencies like the FDA and EMA.

Company Website

To learn more, please visit our website - https://www.biorce.com/

Next Sponsor
Back

Company Information

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. We work With HeartTM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference.

Company Website

To learn more, please visit our website - https://www.parexel.com/

Next Sponsor
Back

Company Information

S-CLINICA is the leader in advanced clinical supply management, specializing in Supply Forecasting, Cost and Risk Analysis, Production Planning and RTSM on a single-platform solution – ClinVision, designed to streamline trial execution.

With built-in supply demand planning and risk analysis, our system enables sponsors to evaluate multiple scenarios and make data-driven decisions to optimize production and distribution.

By supporting continuous planning and real-time updates, ClinVision ensures that supply strategies align with study needs and adapt seamlessly to changes as they happen.

Our proven technology reduces waste, minimizes risk, and accelerates trial timelines, helping biopharma companies execute clinical studies with greater efficiency and confidence.

Company Website

To learn more, please visit our website - http://www.s-clinica.com

Next Sponsor
Back

Company Information

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

Company Website

To learn more, please visit our website - www.SyneosHealth.com

Next Sponsor
Back

Company Information

TFS HealthScience is a global Contract Research Organization (CRO) partnering with biotechnology and pharmaceutical companies throughout their entire clinical development journey. Bringing together nearly 700 professionals, we deliver tailored clinical research services in more than 40 countries. TFS supports customers with comprehensive solutions including full clinical development services, strategic and flexible resourcing. In partnership, we build solution-driven teams of experienced professionals working together for a healthier future. Our mission is to bring treatments to patients faster. For more information, please visit www.tfscro.com.

Company Website

To learn more, please visit our website - www.tfscro.com.

Next Sponsor
Back

Company Information

At TRI, we make RBQM work. Deployed on over 450 clinical trials, we understand the challenges and how to overcome them. Our industry-leading RBQM platform, OPRA, is built by operational experts to support Risk Assessment, Risk Management, and Central Monitoring—all in one intuitive system.

With real-world clinical trial experience, our RBQM team provides the guidance you need to meet regulatory requirements (ICH E6/E8) and confidently embed RBQM at the heart of your trials. That’s why leading global players trust TRI.

We’re not called The RBQM Experts for nothing.

Company Website

To learn more, please visit our website - https://www.tritrials.com/

Next Sponsor
Back

Company Information

EmVenio Clinical Research, a Professional Case Management subsidiary, operates from U.S. and European headquarters with a team of approximately 5,000 professionals supporting clinical trials across more than 80 countries. Our community-based sites and mobile research services expand access for trial participants, while enabling sponsors and CROs to execute high-quality studies at speed and scale with clean, reliable data and consistent results. By bringing trials directly to patients in their homes, communities or places they gather, we enroll populations others miss, helping create a complete and more inclusive picture of human health. Our approach is grounded in empathy, expertise and close collaboration—bridging the gap between science and the people it serves because true progress only happens when research reflects the real world. For more information, please visit emvenio.com.

Next Sponsor
Back

Company Information

Endpoint Clinical is a leading clinical trial technology and service partner, delivering adaptable RTSM solutions with a focus on security, stability, and trust. With decades of expertise and a proactive, innovation-driven approach, Endpoint minimizes friction, reduces risk, and enables your teams to focus where it matters most—on trial success.

Next Sponsor
Back

Company Information

Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.

Company Website

To learn more, please visit our website - https://www.fortrea.com/

Next Sponsor
Back

Company Information

The PPD clinical research business of Thermo Fisher Scientific enable customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, our capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services.

Company Website

To learn more, please visit our website - https://thermofisher.com/ppd

Next Sponsor
Back

Company Information

DISTILL is supported by parent company Solverminds Solutions and Technologies, specialized in building Software products, Low code platforms, AI / ML applications and Business Analytics solutions.

DISTILL can support global and local projects from its offices in Europe, US, India, UAE and Singapore.

Company Website

To learn more, please visit our website - www.distill.biz

Next Sponsor
Back

Company Information

Coquelle Consulting is a trusted partner supporting biotech and pharmaceutical companies in their clinical development journey. We provide highly skilled clinical trial professionals including Trial Managers, Project Managers, TMF Experts, CRAs, Start up Specialists, Data Managers, Vendor Managers, Biostatisticians, Safety Experts and Medical Advisors. Our consultants integrate seamlessly into client teams, bringing clear communication, a collaborative approach and proven expertise that ensures efficiency and precision.

From emerging biotech innovators to established pharmaceutical leaders, we advance clinical success through seamless execution, reliable delivery, and an uncompromising commitment to quality in every project.

Learn more at coquelle-consulting.com

Next Sponsor
Back

Company Information

Evestia Clinical is the specialist CRO for biotech running oncology, rare disease, and neurodegenerative trials. Your program is never a low priority for us. You get direct access to senior leaders from day one. The same team starts and finishes your trial. Your science deserves nothing less.
evestiaclinical.com

Next Sponsor
Back

Company Information

HEMEX is a European CRO supporting pharmaceutical, biotech, and MedTech SMEs with clinical development solutions. Headquartered in Basel and operating globally, we manage multinational trials. Our services include clinical operations, regulatory support, quality assurance, BA/BE and PK studies, patient recruitment, and advanced medical imaging

Company Website

To learn more, please visit our website - https://hemex.ch/

Next Sponsor
Back

Company Information

Founded in 2017, Collective Minds is a medical imaging platform connecting hospitals, scientists, and doctors, which helps organisations running clinical trials and research generate high-quality evidence faster and more efficiently. Headquartered in Stockholm, Collective Minds is built by a specialised team of 40 experts with deep experience in medical imaging and research operations.

Company Website

To learn more, please visit our website - https://collectiveminds.health/

Next Sponsor
Back

Company Information

The CCL Clinical Business Unit is the global specialist of CCL Industries Inc. for products and services in the clinical trials sector. Leveraging over two decades of expertise and operating across various manufacturing sites, we stand poised as your premier partner for clinical trial labeling. With a combined portfolio, worldwide reach, and dedicated local assistance, CCL Clinical emerges as your ultimate destination for excellence in clinical trial labeling services.

Company Website

To learn more, please visit our website - www.CCLClinical.com

Next Sponsor

    Agenda

    • 20 Oct 2026
    • 21 Oct 2026
    Expand All

    8 AM

    Registration and refreshments

    8:20 AM

    Chairperson’s Opening Remarks

    8:30 AM

    KEYNOTE PANEL DISCUSSION Building Resilient Clinical Supply Chains in An Era of Constant Disruption

    • Understanding how recent disruptions including natural events and geopolitical challenges have impacted supply chains
    • Learning how sponsors adapted routes suppliers and timelines to keep trials running
    • Identifying practical strategies to build flexibility visibility and faster decision making into supply operations

     

    1 x Biopharma panel seat available

    1 x Vendor panel seat available

    Speakers

    Kamal Amin
    Head of Clinical Supplies Management, Galderma

    9 AM

    Session reserved for event sponsor

    9:30 AM

    CASE STUDY Using AI in clinical supply: where it is actually working

    • Identifying practical use cases
    • Understanding where AI improves efficiency
    • Avoiding overinvestment

    10 AM

    Session reserved for event sponsor

    10:30 AM

    Morning refreshments and networking break

    11 AM

    Risk Management and Compliance in Pharma Air Freight: Navigating Through Regulatory Challenges

    • Understanding where compliance and operational risks most commonly arise in pharma air freight and global clinical supply logistics
    • Managing regulatory requirements across regions while maintaining shipment integrity and trial timelines
    • Applying practical risk mitigation and contingency planning strategies during transport disruption and temperature excursions

    Speakers

    Mateusz Zawadzki
    Product Manager Special Cargo Certification, International Air Transport Association

    11:30 AM

    Session reserved for event sponsor

    12 PM

    FIRESIDE CHAT De-Risking Supply Chains Without Overcomplicating Operations

    • Balancing flexibility with simplicity
    • Building contingency plans that work
    • Improving communication

    12:30 PM

    Session reserved for event sponsor

    1 PM

    Lunch and networking

    2 PM

    Using IRT to Reduce Supply Risk and Improve Trial Flexibility

    • Understanding how IRT decisions impact clinical supply operations
    • Improving responsiveness during changing enrolment and country expansion
    • Reducing overproduction, waste and unnecessary shipments
    • Connecting IRT data with real-time supply planning
    • Sharing practical lessons from global studies

    Speakers

    Kamal Amin
    Head of Clinical Supplies Management, Galderma

    2:30 PM

    Why Smart Packaging Adoption Is Still Low – And How to Move Forward

    • Understanding barriers to adoption
    • Identifying where it adds value
    • Scaling without overinvestment

    3 PM

    Session reserved for event sponsor

    3:30 PM

    Afternoon refreshments and networking

    4 PM

    LIVE DEBATE Balancing Cost Versus Quality in Clinical Supply And Making The Right Trade-Offs

    • Understanding where reducing cost versus protecting patient safety creates real tension in clinical supply
    • Exploring trade-offs between speed cost and quality versus operational risk and trial integrity
    • Debating when cost reduction is justified versus when it creates unacceptable risk
    • Defining where efficiency gains are possible versus where quality must remain non-negotiable

    Speakers

    Laurynas Dailide
    Senior Category Lead, Novo Nordisk

    4:30 PM

    Session reserved for event sponsor

    5 PM

    Why Clinical Supply Teams Still Struggle to React in Real Time and How to Fix It

    • Understanding why delays still happen despite forecasting planning and risk mitigation strategies
    • Identifying gaps in real-time data visibility and decision-making across supply teams
    • Improving communication between sponsors vendors and sites to enable faster response
    • Building processes that allow supply to adapt quickly to changing trial conditions

    Speakers

    Navid Arshad
    Supply Chain Clinical Trial Study Lead, AstraZeneca

    5:20 PM

    NETWORKING DRINKS

    8:15 AM

    Registration and Refreshments

    8:50 AM

    Chairperson’s opening remarks

    9 AM

    Trial Data in 2027: The Consent and Governance Layer Pharma Can’t Outsource to a CRO

    • What changes for sponsors when EHDS, eIDAS 2.0 wallets, the Data Governance Act and the AI Act converge on clinical trial data infrastructure.
    • Why current consent and audit-trail architectures will not survive a participant's right to revoke or port their data, and what the Nordic region is already building as the working answer: consent evidence ledgers, privacy-preserving computation, and neutral data altruism intermediaries

    Speakers

    Annemette Broch
    Founder & CEO, DATA for GOOD Foundation

    9:30 AM

    Session reserved for event sponsor

    10 AM

    Using AI Tools in Clinical Trials and What Works for Small and Mid-Sized Biotech

    • Sharing practical examples of what has worked (and what hasn’t)
    • Highlighting key challenges and how to overcome them
    • Comparing tools in terms of ease of implementation, cost, and impact for smaller teams
    • Exploring which solutions are realistically adoptable within limited resources and existing systems

    Speakers

    Rasmus Jakobsen
    Senior Manager, Digital Innovation and Execution, Genmab

    10:30 AM

    Morning refreshments and networking break

    11 AM

    Making Clinical Trial Data Work Together and Improving Visibility Across Systems

    • Identifying where fragmented data slows decision making
    • Connecting EDC eCOA and external data sources
    • Defining clear roles to avoid duplication and gaps
    • Improving data review to reduce manual effort
    • Integrating systems without adding complexity

    Speakers

    Ivan Costa Abalo
    Senior Data Manager, Zealand Pharma

    11:30 AM

    Session reserved for event sponsor

    12 PM

    Session reserved for

    Speakers

    Eleni Tokali
    Analyst, GlobalData

    12:30 PM

    Lunch and networking

    1:30 PM

    FIRESIDE CHAT Maintaining Inspection Readiness in Digital and Technology-Enabled Clinical Trials

    • Understanding how digital tools impact inspection readiness and compliance
    • Identifying risks in data integrity audit trails and system use
    • Preparing for inspections when using multiple platforms and vendors
    • Ensuring teams are aligned on documentation and expectations

    2 PM

    Session reserved for event sponsor

    2:30 PM

    PANEL DISCUSSION Making Clinical Trial Technology Work for Sites and Reducing System Burden

    • Understanding how multiple systems increase burden for sites and study teams
    • Identifying where technology slows down rather than supports trial delivery
    • Simplifying workflows across platforms to improve adoption and efficiency
    • Reducing friction without removing valuable data and insights

    Speakers

    Jens Kanstrup Kjær
    Site Manager, Aarhus University Hospital
    Anne Sofie Weigelt Nielsen
    Study Coordinator, Dept. of Hematology, Aarhus University Hospital
    Rasmus Jakobsen
    Senior Manager, Digital Innovation and Execution, Genmab
    Ivan Costa Abalo
    Senior Data Manager, Zealand Pharma

    3:30 PM

    Afternoon refreshments and networking

    4 PM

    ROUNDTABLE SESSIONS

    During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

    Navigating communication styles by tailoring approaches for different patient personalities
    Roel van der Heijde, Facilitator & Trainer, Patient Experience Association The Netherlands

    Managing Clinical Trial Budgets in An Unstable Financial World

    Working Better with Investigative Sites

    Working With CROs More Effectively

    Speakers

    Roel van der Heijde
    Facilitator & Trainer, Patient Experience Association The Netherlands

    5 PM

    End of conference

    Speakers

    Select a speaker to learn more

    Back
    Laurynas Dailide
    Senior Category Lead, Novo Nordisk

    Session Details:

    LIVE DEBATE Balancing Cost Versus Quality in Clinical Supply And Making The Right Trade-Offs

    2026-10-20, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Ivan Vyshnyvetskyy
    Managing Director Ukraine, FutureMeds

    Dr. Ivan Vyshnyvetskyy is a seasoned expert in clinical trials with over 20 years of experience. His expertise spans over 70 clinical trials, including more than 50 as Principal Investigator. As the Managing Director Ukraine, he leads a growing Ukrainian unit of FutureMeds, a top-ranked European professional site network. Dr. Vyshnyvetskyy also serves as the Chair of the Ukrainian Association of Clinical Trials, where he works to enhance cooperation with regulatory bodies, harmonize legislation, and improve clinical trial awareness.  As an Associate Professor at O.O. Bohomolets National Medical University, Dr. Vyshnyvetskyy teaches courses in Research Methodology, Healthcare Management, and Strategic Management.  He holds a PhD in Cardiology from Donetsk National Medical University and a Master of Global Management from American University Kyiv.

    Next speaker
    Back
    Ivanna Rosendal
    Vice President of Business Digitalization, Ascendis
    Next speaker
    Back
    Lene Laursen
    Deputy Director General, Danish Medicines Agency
    Next speaker
    Back
    Rasmus Jakobsen
    Senior Manager, Digital Innovation and Execution, Genmab

    Session Details:

    Using AI Tools in Clinical Trials and What Works for Small and Mid-Sized Biotech

    2026-10-21, 10:00 AM

    Session Details:

    PANEL DISCUSSION Making Clinical Trial Technology Work for Sites and Reducing System Burden

    2026-10-21, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Olivia Vu Van
    Clinical Project Manager, IRLAB
    Next speaker
    Back
    Kirsten Bødker
    Head of Business Relations, Facilitator of Centres for Dementia and Infectious Disease & Immunomodulation, Trial Nation
    Next speaker
    Back
    Roel van der Heijde
    Facilitator & Trainer, Patient Experience Association The Netherlands

    Roel van der Heijde lives in Rotterdam, The Netherlands. He has a MA in International Business, is an international acknowledged NLP trainer, executive team coach and a certified death and grief counsellor.

    He is a driven and experienced trainer and facilitator in:

    • - Patient Fear Reduction (for all caregivers);
    • - Team Collaboration;
    • - Vulnerability & Leadership;
    • - Discrimination & Inclusion.

    Roels motivation: “Acknowledgement and recognition of the fears and emotions of our patients are the basis for excellent patient experience and patient safety”.

    “Working with Groups I experience as thoroughly fascinating and inspiring. In interaction with groups I am every time amazed by the enormous potential of practical knowledge and direct experience that lies hidden in groups and that is so easily overlooked. Herein lies the basis for excellent vulnerable leadership.

    Session Details:

    ROUNDTABLE SESSIONS

    2026-10-21, 4:00 PM

    View In Agenda
    Next speaker
    Back
    Jens Kanstrup Kjær
    Site Manager, Aarhus University Hospital

    Session Details:

    PANEL DISCUSSION Making Clinical Trial Technology Work for Sites and Reducing System Burden

    2026-10-21, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Kamil Sitarz
    Chief Operating Officer, Ryvu Therapeutics

    Kamil Sitarz is Chief Operating Officer and Management Board Member at Ryvu Therapeutics, a European clinical-stage oncology company advancing a diversified pipeline of innovative therapies. He leads corporate strategy, enterprise governance, capital planning, and cross-functional clinical development execution across a diversified oncology portfolio.

    He has been instrumental in transforming Ryvu into a multi-program clinical-stage organization, embedding disciplined portfolio governance and architecting development pathways designed to enhance execution predictability in complex, high-risk oncology settings. His leadership integrates clinical strategy with capital allocation discipline, ensuring alignment across scientific ambition, regulatory positioning, operational design, and financial planning to drive sustainable enterprise value.

     

    Under his direction, Ryvu has built and scaled a robust clinical development organization capable of delivering international Phase I/II programs across challenging hematologic indications and multi-country site networks. He has also played a key role in establishing and governing strategic clinical collaborations with leading global oncology partners, strengthening Ryvu’s development footprint and reinforcing its credibility within the international biotech ecosystem.

     

    With a PhD in Medical Genetics and an Executive MBA, Kamil combines scientific depth with enterprise-level strategic and operational leadership to advance innovation with rigor, accountability, and long-term growth orientation.

    Next speaker
    Back
    Mateusz Zawadzki
    Product Manager Special Cargo Certification, International Air Transport Association

    Session Details:

    Risk Management and Compliance in Pharma Air Freight: Navigating Through Regulatory Challenges

    2026-10-20, 11:00 AM

    View In Agenda
    Next speaker
    Back
    Paivi Worsoe
    Project Manager, Danish Medicines Agency
    Next speaker
    Back
    Maria Koufali
    Life Sciences Industry Director, National Institute for Health and Care Research (NIHR)

    Maria Koufali, is an experienced senior leader in life sciences research and innovation, bringing over 20 years of cross-sector expertise in working with global pharmaceutical companies, digital health firms, diagnostics developers, and MedTech SMEs. She holds a PhD in Pharmacology and Neuroscience, an MBA (Distinction), and is the first NHS R&D Director nationally to be awarded the Nye Bevan Executive Health Leadership Award. Maria currently leads the UK Vaccine Innovation Pathway at NIHR/DHSC, a nationally mandated clinical trials accelerator. In this role, she has delivered over 20 high-priority commercial trials, expanded partnerships beyond Moderna and BioNTech to include smaller biotech firms and large pharma, and embedded site-readiness models and trial metrics to support faster delivery.

    Maria has built a wide network of trusted relationships across the life sciences sector and has consistently translated strategic ambition into operational delivery, regulatory compliance, and commercial value. Previously, as Managing Director of Research & Innovation at Nottingham University Hospitals NHS Trust, she designed and delivered the Trust’s entire NIHR infrastructure portfolio from the ground up, securing funding and oversight for a £70m suite including a BRC, CRF, BioResource, and the Medical Technologies Innovation Facility (MTIF)—a £23m translational platform that supports SMEs to take digital and MedTech innovations from prototype to trial. Under her leadership, the Trust’s commercial research income rose to over £13m per year. She has successfully navigated and aligned MHRA, HRA and ISO frameworks to support industry delivery at scale. Maria currently serves as Trustee and Chair of the Industry Advisory Board at the BBSRC-funded Quadram Institute, where she shapes translational and commercial strategy. She brings a proven ability to develop national infrastructure, deliver commercial growth, and work across government and industry to accelerate innovation that benefits patients and the UK economy.

    Next speaker
    Back
    Annemette Broch
    Founder & CEO, DATA for GOOD Foundation

    Annemette Broch, Founder & CEO, DATA for GOOD Foundation.

    A Professional strategy expert focusing on insights and sharing with more than 30 years experience with predictive modelling, customer orientation and data driven marketing.

    Annemette’s history, passion and experience within datadriven marketing, combined with her own ‘health-experience’ has transformed into a mission of securing individuals control of their own data in order to catalyze responsible activation of personal data.

    In 2018 she founded DATA for GOOD foundation, and the vision is to create a public good based on a neutral governance infrastructure.

    Session Details:

    Trial Data in 2027: The Consent and Governance Layer Pharma Can’t Outsource to a CRO

    2026-10-21, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Navid Arshad
    Supply Chain Clinical Trial Study Lead, AstraZeneca

    Session Details:

    Why Clinical Supply Teams Still Struggle to React in Real Time and How to Fix It

    2026-10-20, 5:00 PM

    View In Agenda
    Next speaker
    Back
    Liselotte Wesley Andersen
    Chairperson, SBONN
    Next speaker
    Back
    Sigrid Schollen
    Clinical Project Lead, Hirundo
    Next speaker
    Back
    Eleni Tokali
    Analyst, GlobalData

    Eleni Tokali, MPharm, MPH, is a Drug Intelligence Analyst at GlobalData. Her primary responsibilities include managing and maintaining GlobalData’s Drugs Database, analyzing drug pipeline information and producing analytical market insight reports. Additionally, Eleni provides timely client support and performs database quality checks. Prior to joining GlobalData, Eleni worked as a registered pharmacist under the General Pharmaceutical Council (GPhC). Eleni has a firm knowledge of pharmaceutical industry dynamics as well as global public health perspectives. Eleni holds a Master of Pharmacy from the University of Brighton and a Master of Public Health from King's College London.

    Session Details:

    Session reserved for

    2026-10-21, 12:00 PM

    View In Agenda
    Next speaker
    Back
    Kamal Amin
    Head of Clinical Supplies Management, Galderma

    Kamal is a trained Chemist who decided to pursue a career in supply chain management and quality. In this role, he was tasked to supervise commercial and clinical trial products. Kamal has worked in the pharmaceutical and device industries for over 15 years in different size organisations ranging from large multinational to small virtual companies. He is currently leading a global team at Galderma to develop an integrated clinical supply chain organisation within the company.

    Session Details:

    KEYNOTE PANEL DISCUSSION Building Resilient Clinical Supply Chains in An Era of Constant Disruption

    2026-10-20, 8:30 AM

    Session Details:

    Using IRT to Reduce Supply Risk and Improve Trial Flexibility

    2026-10-20, 2:00 PM

    View In Agenda
    Next speaker
    Back
    Anne Sofie Weigelt Nielsen
    Study Coordinator, Dept. of Hematology, Aarhus University Hospital

    Session Details:

    PANEL DISCUSSION Making Clinical Trial Technology Work for Sites and Reducing System Burden

    2026-10-21, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Ivan Costa Abalo
    Senior Data Manager, Zealand Pharma

    Ivan Costa Abalo is a Senior Clinical Data Manager at Zealand Pharma, where he drives data management activities across fully outsourced clinical trials, overseeing CRO collaboration, trial-specific deliverables, and data management workflows. He works closely with cross-functional teams to ensure data quality, compliance, and alignment with internal standards throughout the trial lifecycle.

    Prior to joining Zealand Pharma, Ivan worked at Novo Nordisk as a Clinical Trial Data Manager, where he contributed to process optimisation initiatives and helped establish clearer responsibilities and procedures in omics data management.

    With experience spanning both large-scale pharma and a focused clinical-stage biotech, Ivan brings a practical perspective on what it takes to make clinical trial data work across complex, multi-vendor environments.

    Session Details:

    Making Clinical Trial Data Work Together and Improving Visibility Across Systems

    2026-10-21, 11:00 AM

    Session Details:

    PANEL DISCUSSION Making Clinical Trial Technology Work for Sites and Reducing System Burden

    2026-10-21, 2:30 PM

    View In Agenda
    Next speaker
    Back
    Stephan Christgau
    Founding Partner, Eir Ventures

    Stephan Christgau is a founding partner of the Nodic life science venture fund Eir Ventures, and an experienced life science investor with a strong background in both preclinical and clinical development. With a proven track record across the European and US biotech landscapes, he brings deep expertise from academia and industry alike. His career is grounded in scientific excellence, reflected in over 60 peer-reviewed publications and more than 30 patent applications. With almost two decades as a life science venture investor, Stephan has been involved in formation and financing of more than 25 biotech companies that have advanced innovative project through to clinical validation.

    Next speaker

    Advisory Board

    Select a member to learn more

    Back
    Chris Wallace
    Head of Distribution EMEA, Argenx

    Chris has over 35 years’ varied supply chain experience, having worked for several blue chip companies in a number of industries including 3rd party logistics services, automotive, medical device, nuclear fuels and biotech/pharmaceuticals.

    Originally from the UK but now based in Switzerland, he has been involved in life science - biotech/pharmaceuticals & medical device - for over 20 years of his career and has latterly been SVP Global Supply Chain at Clover Biopharmaceutical before last year moving to Argenx as Head of Distribution EMEA.

    He has developed, implemented and managed global healthcare supply chain strategies and operations on 6 continents. This has included different set-ups in multiple countries, including many in the Emerging Markets as well as the developed world.

    Chris has a degree in economics from Manchester University, an MBA from Aston University and a postgraduate diploma from London University. In his spare time, he plays golf badly and loves to sample great Italian food and red wines!

    Next
    Back
    Luiz Barberini
    Head of External Manufacturing, Latin America, Bayer
    • Over 25 years’ experience in Logistics, Supply Chain, Procurement and Demand Planning areas.
      Solid knowledge and experience in the whole S&OP process and its KPI´s inter-relationships with stakeholders
    • Demand Planning process management - pre-S&OP, with Sales, Marketing, Trade Marketing, Industrial Planning and Finance and customized tool design for such process
    • Management skills: experience with multidisciplinary and international teams (Brazil / Latin America / US).
    • Experience in S&OP, 3PL and Supply Chain Organization projects' implementation
    • Strong experience with Pharmaceutical and Consumer companies and Brazilian distribution model / 3PL contracts
    • Solid team management skills, as well as Customer Service relationship and management
    • Teacher for major Post Graduation Schools - Demand Planning and Procurement/Negotiation areas

    CSCP & CPIM APICS. Logistics & Supply Chain driven strategy. Distribution & Logistics, Demand Planning, S&OP, Procurement and Export experiences, focusing on Business necessities through effective leadership.

    Working as External Manufacturing Operations Manager Latin America at Bayer, in charge for external partners for CHC Division. Previously as Relationship Associated Director at Merck , Logistics Manager at Takeda/Nycomed Pharma, focusing on demand management, planning and distribution activities. Also has worked as Pfizer´s Logistic Manager and EFD´s Supply Chain Manager. Souza Cruz´s Procurement Manager and Rhodia's Logistic Supervisor.

    Specialties: Logistics, Supply Chain, Materials, Procurement , Services, Negotiation, 3PL contracts, S&OP, Demand Planning

    Next
    Back
    Amanda Briceno
    Clinical Supply Management & Patient Centricity Unit Manager, Chiesi Farmaceutici

    Amanda Briceno is an experienced clinical supply professional with over 10 years in clinical research and supply chain operations. Originally from Venezuela, now based in Italy. She currently serves as Clinical Supply Manager and Head of the Patient Centricity Unit at Chiesi Farmaceutici, where she leads initiatives to design and deliver patient-focused clinical supply solutions that improve trial compliance and enhance the experience of both patients and site staff.

    Her career began as a Clinical Research Associate at IQVIA, where she gained extensive experience in global trial monitoring and operations. Since joining Chiesi, Amanda has held positions of increasing responsibility within the Clinical Supply department, before assuming her current leadership role.

    Amanda holds a Master’s degree in Drug Biotechnology from the Università degli Studi di Milano and a Bachelor’s degree in Medical Biotechnology. Amanda brings a strong blend of technical knowledge and operational leadership. Passionate about innovation in clinical supplies, she is dedicated to advancing more accessible, patient-centric clinical trials.

    Next
    Back
    Paul Hingst
    Supply Chain Consultant, Crinetics Pharmaceuticals

    Paul is an experienced Clinical Supply Chain Professional with a 25-year career in the BioPharmaceutical industry.  His extensive career includes roles at major companies like Amgen and Thermo Fisher Scientific, where he honed his skills and made a significant impact.  He has served in varied roles from basic research and contract manufacturing to client services and account management.  He is a Principal Consultant and Co-Founder of Beacon BioPharm Associates, a clinical supply chain consulting firm, providing variable staffing solutions to small and mid-sized BioPharm clients.  Paul is an industry veteran and respected leader known for his expertise in clinical supply chain.

    Next
    Back
    Amaury Jeandrain
    Strategy Advisor, Clinical Supply, N-SIDE

    Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain optimization. He joined Clinigen in 2015, then N-SIDE in 2016 where he last  held the position of VP of Strategy for clinical supply solutions.

    Over the past decade, his objective has been to make clinical trial supply chains more efficient by redefining CTS strategies and driving measurable performance improvements. His expertise also includes forecasting, planning, waste reduction, and shortage risk mitigation.

    Since 2024, while accompanying his wife on humanitarian missions abroad (Niger, then Colombia), Amaury has continued his work as a CTS advisor and trainer, partnering with pharmaceutical companies worldwide to enhance clinical supply performance.

    Next
    Back
    Francesco Santo
    Director Clinical Supply Chain,
    Orano Med

    A highly experienced and passionate Director Clinical Supply Chain, Francesco has dedicated the past 17 years to ensuring the seamless execution of clinical trials by optimizing supply chain operations. His deep commitment to this field is driven by a relentless pursuit of excellence in delivering life-saving treatments to patients worldwide.  Throughout his career, he has honed a diverse skill set, encompassing:

    • Strategic Supply Chain Management
    • Regulatory Compliance
    • Cross-Functional Collaboration
    • Risk Management
    • Innovative Problem-Solving

    Francesco’s dedication to the clinical supplies industry is rooted in a profound understanding of the critical role it plays in advancing medical research and improving patient outcomes. He is committed to continuing his journey in this field, always striving to contribute to the betterment of global health.

    Next
    Back
    Arnaud Dourlens
    Global Head of Clinical Supply Chain Operations, Sanofi

    Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group.

    During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio.

    Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

    Next
    Back
    Paul Larochelle
    Senior Director Global Clinical Supply Chain,
    Takeda

    Paul Larochelle currently serves as Senior Director (Planning Team Lead) for Global Clinical Supply Chain at Takeda, where he serves as a member of the GCSC Leadership Team and is responsible for managing a team of professionals overseeing the forecasting and planning of clinical study supplies. His role encompasses the strategic and operational aspects of clinical supply chain management in therapeutic areas such as oncology, neuroscience, gastrointestinal diseases, vaccines, and rare diseases. Paul's leadership extends to cross-functional projects aimed at implementing new capabilities, conducting due diligence of potential acquisitions by the company, and improving existing processes.

    Previously, Paul held various roles at Biogen Corporation and Genzyme, a Sanofi Company, where he honed his expertise in clinical asset planning and clinical supplies management. His contributions to these organizations included serving as a lead contact for multiple clinical programs, developing supply chain strategies, leading continuous improvement projects, and serving as Fellowship Coordinator and Student Preceptor for dozens of students.

    Paul has a BS in Biology from Providence College, PharmD from MCPHS Boston, and an MBA from Worcester Polytechnic Institute. He also completed a Post-PharmD Industry Fellowship in Clinical Research/Investigational Product Management with MCPHS-Worcester and Genzyme Corporation. He is Chair of the Dean's Advisory Board at MCPHS School of Pharmacy – Boston,  a member of the Pharmacy Advisory Board at Western New England University, and a member of the Advisory Board for the Clinical Trial Supply global conference series.

    Next

    Plan Your Visit

    Venue

    Clarion Hotel & Congress Copenhagen Airport

    Clarion Hotel & Congress Copenhagen Airport, Kastrup,Denmark, 2770

    Book Your Stay

    Accommodation

    Arena International Events Group “(Arena”) is aware of numerous third-party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings, events attendee lists and selling unsolicited services. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third-party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third-party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group..

    Sponsors

    Select a sponsor to learn more

    FEATURED SPONSORS

    SESSION SPONSORS

    Technology Showcase

    Pens/Notepads and Tote Bag Sponsor

    Prize Draw Sponsor

    LANYARD SPONSOR

    Drinks Reception Sponsor

    EXHIBITOR

    Co-Sponsor

    Event Partner

    Why partner?

     

    Contact us to become a partner

    Partnership Opportunities

    We work with you to design a bespoke package to meet your business needs, where you could:

    • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
    • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
      Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
    • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

    Event reach

    • 200+ attendees each year
    • 80% attendees C-suite level

     

    Take a look at our current sponsors

    Resources

           
           
       
    Become A Media Partner

    Enquiry

    Contact Us

    SPONSORSHIP ENQUIRIES

    Jarvinder Sidhu

    Senior Sponsorship Manager

    +44 207947 2755

    SPEAKER ENQUIRIES

    Ralitsa Pashkuleva

    Principal Producer

    +44 020 7661 7976

    MARKETING ENQUIRIES

    Valentina Sidore

    Head of Marketing

    DELEGATE ENQUIRIES

    Sunny Saikia

    VIP Delegate Manager

    SPONSORSHIP ENQUIRIES

    Senior Sponsorship Manager

    Jarvinder Sidhu


    +44 207947 2755

    SPEAKER ENQUIRIES

    Principal Producer

    Ralitsa Pashkuleva


    +44 020 7661 7976

    MARKETING ENQUIRIES

    Head of Marketing

    Valentina Sidore


     

    DELEGATE ENQUIRIES

    VIP Delegate Manager

    Sunny Saikia